All News

According to a new report by the American Association for Cancer Research, the number of survivors living in the United States rose by one million between 2014 to 2016. This demonstrates real progress, according to Nancy Davidson, M.D.

CURE spoke with David Reardon about immunotherapy and the future of treating brain cancer.

Hammonds discusses how she leaves the scary stuff behind and focuses, instead, on the good stuff after ovarian cancer.

Every person who crosses our paths has something to teach us. Here's what I learned from my kind, silent and bonus friends during cancer.

Jedd D. Wolchok discusses the future of immunotherapy in melanoma treatment.

While many new treatment options have been introduced for kidney cancer in recent years, the question of how to sequence them is still being debated.

When my feline companion developed cancer, quality of life became more important than quantity of days.

Three words no one wants to hear

Communication for any two people in a relationship can be challenging, but can be especially so when one partner has advanced cancer.

Because cancer is an invisible disease, most patients can keep it under wraps when out in public, but there are some instances when we need to play 'the cancer card.'

Women with stage 1 endometrioid adenocarcinoma of the uterus showed improved survival with vaginal brachytherapy (VB), according to a large database analysis published in the journal Cancer.

Tecentriq (atezolizumab) has been found to be non-toxic and has demonstrated a major survival advantage in patients with metastatic urothelial bladder cancer.

The FDA voted against approving Qapzola for treatment of some patients with bladder cancer.

As a survivor of cancer, life has enough difficulty without daily painful reminders. Let go of items that create emotional clutter today.

Sometimes I drive myself a little crazy wondering what I did to get breast cancer (even though I know logically why I likely did). I think too much. I am pretty sure I am not alone in this. Cancer survivors, including me, really should try to lose the Blame Game.

Educate, engage and energize — those are the three main verbs and goals of the Bladder Cancer Advocacy Network’s (BCAN) first ever leadership summit.

A recent study showed a correlation between higher body mass index and survival in some patients with kidney cancer.

Novel therapeutic agents have been developed for chronic lymphocytic leukemia (CLL), but their advantage over traditional treatments for this type of cancer have yet to be proved.

Does the fear of recurrence ever truly end for a breast cancer survivor and how do we negate its power over us?

Ed completes the last two of four chemo cycles without any AFIB episodes.

Chase After a Cure is running a Thunderclap campaign on Sept. 15 and is asking people to be flashy for a good cause: awareness and funds for childhood cancers.

Confronted by a simple question, this cancer patient finds a new perspective on health.

September is national Ovarian Cancer Month. My wife died of ovarian cancer at the age of 47. Her final wish was to swim with crocodiles. This is her story.

The NOCC is connecting women who have ovarian cancer to others who are experiencing similar struggles.

Most people don't know much about kidney cancer at the time of their diagnosis. The Kidney Cancer Association wants to change that.

The novel agent rucaparib was granted a priority review for the treatment of patients with BRCA-positive advanced ovarian cancer who have received at least two prior lines of chemotherapy.

Johnson discusses the challeneges of navigating medication management at home.